Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 29 Apr, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Recent Articles
- Musk Portrays Altman As Schemer Who Misled Him
- S. Korea Exports Seen Rising Sharply Again in April on Chip Boom
- House Democrats Urge Trump to Keep Ban on Chinese Cars
- China Tech Firms Scramble for Huawei AI Chips after DeepSeek V4 Launch
- US Orders Halt on Chip Equipment Shipments to China's No. 2 Chipmaker
- Spot Crude Premiums Ease Despite Hormuz Closure
- Trump Approval Sinks to New Low on Living-Cost Jump from Iran Adventure
- LG Electronics, Nvidia Mull Pact on Robots, AI data Centrer and Mobility
- Starbucks Shares Rise on Signs of Turnaround
- Robinhood Shares Fall as Crypto Slump Dents Trading Volume Growth
